Molecular Epidemiology of Non-Hodgkin Lymphoma Survival

Contact: James R. Cerhan, M.D., Ph.D.

Number of Enrolled Cancer Patients/Survivors: Ongoing (currently >4500)
Years of Diagnoses of Enrolled Cancer Patients/Survivors: 2002-current
Approximate Years of Follow-up: Median follow-up on living patients is 3 years (max.: 9 years)
Cancer Sites Represented: Non-Hodgkin Lymphoma (including CLL)
Biological Specimens Collected: Blood/Blood Fraction
Buccal Cells
Germline DNA
Formalin Fixed Tumor Tissue
Fresh Frozen Tumor Tissue
Treatment Outcome Measures: Physician/Medical Record Reported
  • Cancer Recurrence
  • Death
Patient-Reported
  • Late Medical Event
  • Quality of Life
  • Cancer Recurrence
  • Death
  • Other: Psychosocial
Co-morbidities at Study Entry: Diabetes
Heart Disease
Pulmonary Disease
Other
Lifestyle Factors: Smoking
Alcohol Use
Diet
Physical Activity
Body Mass Index
Weight Loss/Control
Other
Treatment Data: Surgery
Radiation
Chemotherapy
Hormonal Therapy
Bone Marrow/Stem Cell Transplant
Other
Treatment Data Assessed By: Electronic Record
Chart Abstraction
Patient Reported Questionnaire
Is the study open to collaboration? Yes

Return to Top